FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

782977003: Larotrectinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3757031016 Larotrectinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3757032011 Larotrectinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Larotrectinib (substance) Is a Enzyme inhibitor false Inferred relationship Some
Larotrectinib (substance) Is a Pyrazole derivative true Inferred relationship Some
Larotrectinib (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Larotrectinib (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Larotrectinib (substance) Is a Pyrimidine true Inferred relationship Some
Larotrectinib (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing larotrectinib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Larotrectinib (substance) Inferred relationship Some 1
Larotrectinib-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Larotrectinib (substance) Inferred relationship Some 1
Product containing only larotrectinib in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Larotrectinib (substance) Inferred relationship Some 1
Larotrectinib only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Larotrectinib (substance) Inferred relationship Some 1
Larotrectinib sulfate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Larotrectinib (substance) Inferred relationship Some
Larotrectinib (as larotrectinib sulfate) 20 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Larotrectinib (substance) Inferred relationship Some 1
Larotrectinib (as larotrectinib sulfate) 100 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Larotrectinib (substance) Inferred relationship Some 1
Product containing precisely larotrectinib (as larotrectinib sulfate) 25 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Larotrectinib (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start